Katalyze AI’s Digityze AI, launched on Snowflake Marketplace, transforms biomanufacturing with AI-powered document intelligence, ensuring compliance and efficiency.
Katalyze AI, a leader in AI-driven biomanufacturing solutions, announced the launch of Digityze AI on the Snowflake AI Data Cloud on July 8, 2025. This innovative document intelligence platform, available on Snowflake Marketplace, leverages advanced machine learning, biophysics-informed models, and visual AI to convert unstructured documents into structured, compliant data. Designed for biopharmaceutical and highly regulated industries, Digityze AI streamlines processes, reduces waste, and accelerates the production of life-saving drugs.
Digityze AI launched on Snowflake Marketplace for biomanufacturing.
Transforms PDFs, handwritten notes, and forms into structured data.
Integrates generative AI and large language models for compliance.
Enables real-time analytics, reducing waste and production timelines.
Built as a Snowflake Native App for seamless, secure integration.
Supports industries like biotech with high accuracy and auditability.
Digityze AI addresses the challenge of fragmented, unsearchable documents like Certificates of Analysis (CoAs), batch records, and lab reports. By automating data extraction, validation, and approval, it eliminates manual bottlenecks, enabling real-time analytics. “Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste and improve output, all while maintaining stringent regulatory compliance,” said Reza Farahani, CEO of Katalyze AI. The platform’s modular workflows and human oversight ensure both accuracy and auditability for regulated environments.
Built as a Snowflake Native App, Digityze AI operates within customers’ Snowflake environments, ensuring secure, governed data integration. “Katalyze AI’s commitment to helping Snowflake empower every enterprise to achieve its full potential through data and AI can be seen through the launch of Digityze AI,” said Shannon Katschilo, Country Manager of Canada, Snowflake. This eliminates data silos, enhances process visibility, and supports rapid adoption across Snowflake’s network of over 9,000 enterprises, including biotech leaders.
Digityze AI combines generative AI, raw material characterization, and large language models to process complex documents, delivering actionable insights. It reduces deviations, improves yield, and ensures compliance with regulatory standards, addressing key biopharma challenges. The platform’s 40+ built-in connectors enable deployment in weeks without altering existing infrastructure, making it a scalable solution for pharmaceutical manufacturers.
By unlocking insights from unstructured data, Digityze AI empowers biopharma companies to optimize production, reduce costs, and accelerate time-to-market for critical therapies. Its integration with Snowflake’s AI Data Cloud positions Katalyze AI as a trusted partner for life sciences, driving innovation in a highly regulated industry. This launch marks a significant step toward smarter, data-driven biomanufacturing.
About Katalyze AI
Katalyze AI provides an AI-driven biomanufacturing platform designed to support biotech and pharmaceutical manufacturers in analyzing raw materials, optimizing production processes, and enhancing operational efficiency. By focusing on yield improvement, quality consistency, and demand reliability, Katalyze AI addresses key challenges in biomanufacturing to support reliable, data-informed production outcomes. The platform is built to integrate seamlessly into existing workflows, enabling manufacturers to make informed decisions and drive sustainable growth.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.